2[1]Cheung MC, Brown BG, Wolf AC. Altered particle size distribution of apolipoprotein AI-containing lipoproteins in subjects with coronary artery disease. J Lipids Res,1991;32(3):383.
3[3]Barrans A, Jarspard B, Barbaras R. Pre β-HDL: structure and metabolism. Biochim Biophys Acta,1996;1300(1):73.
5[5]Miida T, Nakamura Y, Inano K. Pre β1-high-density lipoprotein increases in coronary artery disease. Clinical Chemistry,1996;42(12):1992.
6[6]Asztalos BF,Roheim PS,Milani RL. Distrubution of apoAI-containing HDL subpopulations in patients with coronary heart disease. Aterioscler Thromb Vasc Biol,2000;20(12):2670.
7[8]Saidi Y,Sich D,Camproux A. Interlationships between postprandial lipoproteinB:CⅢ particle changes and high-density lipoprotein subpopulation profiles jin mixed hyperlipoproteinemia. Metabolism,1998;48(1):60.
8[9]Lee M, Kim JQ, Kim J, et al. Studies on the plasma lipid profiles, and LCAT and CETP activities according to hyperlipoproteinemia and combined hyperlipidemia. Aterioscler Thromb Vasc Biol,1995;15(1):112.
9[10]Freedman DS, Bowman BA,Srinivasan SR. Distribution and correlates of high-density lipoprotein subclasses among children and adolescents. Metabolism,2001;50(3):370.
10[12]Wang T,Chen W,Chien K, et al. Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in Chinese population. Am J Cardiol,2001;88(7):737.
